MILPHARM ApS: Financial statements 2019
CVR: 35814159
Source: annual report 2019, Danish Business Authority
01/07/2018 – 30/06/2019
MILPHARM ApS (CVR 35814159) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -8,123 and a net result of DKK 90,967 compared with DKK -86,074 the year before. Equity in the 2019 report amounted to DKK 164,396. The solvency ratio was 34.7%.
- Gross Profit
- DKK -8,123
- Profit/Loss
- DKK 90,967
- Equity
- DKK 164,396
- Total Assets
- DKK 474,321
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -8 t. | 91 t. | 164 t. | 0 |
| 2018 | - | -8 t. | -86 t. | 73 t. | - |
| 2017 | - | -7 t. | -10 t. | 160 t. | - |
| 2016 | - | -7 t. | 39 t. | 170 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout MILPHARM ApS
MILPHARM ApS was a Danish company of the type Anpartsselskab based in Slagelse, founded in 2014. The company has been dissolved on 24 June 2022. The company was registered under the industry Investeringsselskaber. According to the 2021 annual report, the company had an average of 0 employees. In 2021, the company reported a gross profit of DKK -1,867 and a net result of DKK 175,681 compared with DKK 274,792 the year before. Equity in the 2021 report amounted to DKK 614,869.